Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci
Blood · 2023
DOI: 10.1182/blood.2022017378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Andrea Calabria und 16 weiteren Autor:innen. Beteiligte Einrichtung: San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Genetic Vectors, Genetic Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Adeno-associated Viral vectors (AAVs) have been successful exploited in gene therapy applications for the treatment of several genetic disorders. AAV is considered an episomal vector but it has been shown to integrate within the host-cell genome following generation of double-strand DNA breaks or nicks. While AAV integration raises some safety concerns, it can also provide therapeutic benefit; the direct intrathymic injection of an AAV harboring a therapeutic transgene results in integration in T cell progenitors and long-term T cell immunity. To assess the mechanisms of AAV integration, we retrieved and analyzed hundreds of AAV integration sites from lymph node-derived mature T-cells as compared to liver and brain tissue from treated mice. Notably, we found that while AAV integrations in the liver and brain were distributed across the entire mouse genome, >90% of the integrations in T-cells were clustered within the T cell receptor α, β and γ genes. More precisely, the insertion mapped to DNA breaks created by the enzymatic activity of recombination activating genes (RAG) during V(D)J recombination. Our data indicate that RAG activity during T-cell receptor maturation induces a site-specific integration of AAV genomes and opens new therapeutic avenues for achieving long-term AAV-mediated gene transfer in dividing cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique (CNRS), Paris, France.
- Stem Cell and Neurogenesis Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Neuroscience Institute, National Research Council of Italy, Milan, Italy.
- Translational Gene Therapy Laboratory, INSERM and Nantes University, Nantes, France.
- Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
ORCID-Profile: Andrea Calabria, Carlo Cipriani, Laura Rudilosso, Simona Esposito, Mirko Luoni, Serena Giannelli, Mickael Guilbaud, Oumeya Adjali, Naomi Taylor, Eugenio Montini, Daniela Cesana
Zitieren
APA
Calabria, A., Cipriani, C., Spinozzi, G., Rudilosso, L., Esposito, S., Benedicenti, F., Albertini, A., Pouzolles, M., Luoni, M., Giannelli, S., Broccoli, V., Guilbaud, M., Adjali, O., Taylor, N., Zimmermann, V. S., Montini, E., & Cesana, D. (2023). Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci. Blood. https://doi.org/10.1182/blood.2022017378
Vancouver
Calabria A, Cipriani C, Spinozzi G, Rudilosso L, Esposito S, Benedicenti F, et al. Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci. Blood. 2023. doi:10.1182/blood.2022017378
BibTeX
@article{Calabria2023,
author = {Calabria, Andrea and Cipriani, Carlo and Spinozzi, Giulio and Rudilosso, Laura and Esposito, Simona and Benedicenti, Fabrizio and Albertini, Alessandra and Pouzolles, Marie and Luoni, Mirko and Giannelli, Serena and Broccoli, Vania and Guilbaud, Mickael and Adjali, Oumeya and Taylor, Naomi and Zimmermann, Valérie S and Montini, Eugenio and Cesana, Daniela},
title = {Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022017378}
}
EUVIMED